Shree Ganesh Remedies share news, announcements and annual reports
NSE: SGRLBSE: 540737Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹639.75.
30 Oct: open ₹639.75, high ₹651.85, low ₹610.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹792 Cr1,715th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 65.44
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.78
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 7.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.16
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 7,62259.3% delivered
Shree Ganesh Remedies share news and announcements
463 announcements, routine notices left out, newest first. Page 4 of 10.
Nov 2023
10 Nov · Results
10 Nov · Board meeting
1 Nov · Board meeting
Meeting on 10 Nov 2023: quarterly results
Oct 2023
25 Oct · Analysts
Sep 2023
23 Sep · Analysts
21 Sep · Analysts
18 Sep · Meeting
4 Sep · Disclosure
Aug 2023
28 Aug · Dividend
26 Aug · Reg. 34 (1) Annual Report.
21 Aug · Disclosure
Jul 2023
31 Jul · Business
31 Jul · Business
31 Jul · Management
31 Jul · Results
31 Jul · Results
24 Jul · Board meeting
Meeting on 31 Jul 2023: quarterly results
Jun 2023
20 Jun · Analysts
12 Jun · Analysts
May 2023
30 May · Results
Apr 2023
26 Apr · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
26 Apr · Board meeting
Meeting on 30 May 2023: final dividend and audited results
Feb 2023
28 Feb · Board meeting
Meeting on 28 Feb 202328 Feb · Announcement under Regulation 30 (LODR)-Allotment
28 Feb · Board meeting
Jan 2023
27 Jan · Corporate action
24 Jan · Board meeting
20 Jan · Board meeting
Meeting on 24 Jan 2023: rights issue16 Jan · Results